Harvard Bioscience
HBIO
HBIO
94 hedge funds and large institutions have $142M invested in Harvard Bioscience in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 14 closing their positions.
Holders
94
Holders Change
-6
Holders Change %
-6%
% of All Funds
1.5%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
40
Reduced
27
Closed
14
Calls
$101K
Puts
$59K
Net Calls
+$42K
Net Calls Change
-$121K
Top Buyers
1 |
GIM
1
Granahan Investment Management
Waltham,
Massachusetts
|
$7.46M |
2 |
2C
2
272 Capital
Dallas,
Texas
|
$14M |
3 |
AE
3
AMH Equity
Great Neck,
New York
|
$9.21M |
4 |
4
BlackRock
New York
|
$11.8M |
5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$8.32M |